Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes

Biochemical and Biophysical Research Communications
Zandong YangJerry L Nadler

Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disease leading to near complete pancreatic beta-cell destruction. New evidence suggests that beta-cell regeneration is possible, but ongoing autoimmune damage prevents restoration of beta-cell mass. We tested the hypothesis that simultaneously blocking autoimmune cytokine damage and supplying a growth-promoting stimulus for beta-cells would provide a novel approach to reverse T1DM. Therefore, in this study we combined lisofylline to suppress autoimmunity and exendin-4 to enhance beta-cell proliferation for treating autoimmune-mediated diabetes in the non-obese diabetic (NOD) mouse model. We found that this combined therapy effectively reversed new-onset diabetes within a week of therapy, and even maintained euglycemia up to 145 days after treatment withdrawal. The therapeutic effect of this regimen was associated with improved beta-cell metabolism and insulin secretion, while reducing beta-cell apoptosis. It is possible that such combined therapy could become a new strategy to defeat T1DM in humans.

References

Dec 18, 2003·Annals of the New York Academy of Sciences·Zandong YangJerry L Nadler
Mar 26, 2004·Journal of Autoimmunity·Zandong YangJerry L Nadler
Dec 14, 2004·Biochemical Pharmacology·Zandong YangJerry L Nadler
Dec 29, 2004·Transplantation Proceedings·Z YangJ L Nadler
Jan 5, 2005·The Journal of Clinical Investigation·Massimo Trucco
Feb 15, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Zandong YangJerry L Nadler
Jul 9, 2005·Nature Biotechnology·Susan Bonner-Weir, Gordon C Weir

❮ Previous
Next ❯

Citations

Jul 7, 2012·Current Diabetes Reports·Claire M Issa, Sami T Azar
Jan 11, 2007·The Journal of Experimental Medicine·Kristin V TarbellRalph M Steinman
Jun 10, 2010·The Journal of Clinical Investigation·Jeffrey M SturekCatherine C Hedrick
Dec 8, 2007·Endocrinology·Irene HadjiyanniDaniel J Drucker
Jan 22, 2010·The Journal of Clinical Endocrinology and Metabolism·K MaJ L Nadler
Sep 12, 2013·PloS One·Christian W GrantLisa M Spain
Jan 18, 2008·World Journal of Gastroenterology : WJG·Andreas Sturm, Axel U Dignass
Jun 29, 2010·Indian Journal of Pharmaceutical Sciences·C K Chakraborti
May 7, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jeremy PettusSteven Edelman
Feb 17, 2009·Journal of Diabetes and Its Complications·Song XueMichael J Haller
Jun 16, 2007·Metabolism: Clinical and Experimental·Francesca M CoutoAnath Shalev
Nov 28, 2006·Journal of Cellular and Molecular Medicine·A SantanaE Roche
Jan 6, 2009·Annals of the New York Academy of Sciences·Alexander Fleming
Jul 1, 2011·Experimental Diabetes Research·Bernard PorthaJamileh Movassat
Aug 12, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Moufida Ben NasrPaolo Fiorina
Dec 12, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Artur ŚwierczekJacek Mlynarski
Feb 1, 2007·Current Opinion in Organ Transplantation·Michael F Crutchlow, Doris A Stoffers
Oct 18, 2007·Endocrinology·Irene Hadjiyanni, Daniel J Drucker
Mar 1, 2007·Expert Review of Endocrinology & Metabolism·Christophe M Filippi, Matthias G von Herrath
Oct 29, 2010·Expert Review of Clinical Immunology·Rodolfo José Chaparro, Teresa P Dilorenzo
Oct 12, 2007·Physiological Reviews·Jens Juul Holst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.